NO843563L - Fremgangsmaate ved fremstilling av farmasoeytiske preparater med hoeyt innhold av aktiv bestanddel som frigjoeres over lengre tid - Google Patents

Fremgangsmaate ved fremstilling av farmasoeytiske preparater med hoeyt innhold av aktiv bestanddel som frigjoeres over lengre tid

Info

Publication number
NO843563L
NO843563L NO843563A NO843563A NO843563L NO 843563 L NO843563 L NO 843563L NO 843563 A NO843563 A NO 843563A NO 843563 A NO843563 A NO 843563A NO 843563 L NO843563 L NO 843563L
Authority
NO
Norway
Prior art keywords
procedure
long time
active ingredients
pharmaceutical preparations
high content
Prior art date
Application number
NO843563A
Other languages
English (en)
Inventor
Pal Fekete
Tibor Kovacs
Denes Bezzegh
Ilona Bor
Zoltan Toth
Katalin Zukovics
Eva Tamas
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of NO843563L publication Critical patent/NO843563L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
NO843563A 1983-01-26 1984-09-07 Fremgangsmaate ved fremstilling av farmasoeytiske preparater med hoeyt innhold av aktiv bestanddel som frigjoeres over lengre tid NO843563L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU83245A HU187215B (en) 1983-01-26 1983-01-26 Method for producing pharmaceutical product of high actor content and prolonged effect

Publications (1)

Publication Number Publication Date
NO843563L true NO843563L (no) 1984-09-07

Family

ID=10948692

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843563A NO843563L (no) 1983-01-26 1984-09-07 Fremgangsmaate ved fremstilling av farmasoeytiske preparater med hoeyt innhold av aktiv bestanddel som frigjoeres over lengre tid

Country Status (15)

Country Link
US (1) US4748023A (no)
JP (1) JPS60500213A (no)
BE (1) BE898888A (no)
CH (1) CH661659A5 (no)
DE (1) DE3490030T1 (no)
DK (1) DK457984A (no)
FI (1) FI843773A7 (no)
FR (1) FR2559389B1 (no)
GB (1) GB2143734B (no)
HU (1) HU187215B (no)
NL (1) NL8420009A (no)
NO (1) NO843563L (no)
SE (1) SE458092B (no)
SU (1) SU1535369A3 (no)
WO (1) WO1984002843A1 (no)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3532692A1 (de) * 1985-09-13 1987-03-19 Boehringer Mannheim Gmbh Verfahren zum herstellen von tabletten aus pellets
NZ217813A (en) 1985-10-21 1991-01-29 Grace W R & Co Dipeptides and process for their preparation using an enzyme coupling agent
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
WO1987006828A1 (en) * 1986-05-16 1987-11-19 The State Of Victoria Biocompatible implants
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
WO1988002629A1 (en) * 1986-10-16 1988-04-21 American Health Products Corporation 2',3'-didesoxyadenosine composition
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
US4904474A (en) * 1988-01-25 1990-02-27 Alza Corporation Delivery of drug to colon by oral disage form
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
JP2514078B2 (ja) * 1988-08-22 1996-07-10 エスエス製薬株式会社 圧縮成型製剤
HU201869B (en) * 1988-12-30 1991-01-28 Egyt Gyogyszervegyeszeti Gyar Process for producing microcapsules of quick dissolving active component
JP3011752B2 (ja) * 1990-10-23 2000-02-21 フロイント産業株式会社 徐放性製剤およびその製造方法
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
AU1193092A (en) * 1992-01-10 1993-08-03 Obschestvo S Ogranichennoi Otvetstvennostju Meditsinsky Nauchno-Proizvodstvenny Komplex Biotiki Granulated pharmaceutical composition and method of obtaining it
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
AU5135898A (en) * 1996-12-03 1998-06-29 Schering-Plough Kabushiki Kaisha Controlled release matrix tablet and method for its preparation
US7179486B1 (en) * 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
HU221435B (en) * 1998-02-20 2002-10-28 Egyt Gyogyszervegyeszeti Gyar Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production
WO2001015665A1 (en) 1999-09-02 2001-03-08 Nostrum Pharmaceuticals, Inc. Controlled release oral dosage suitable for oral administration
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
AU2002217647A1 (en) * 2000-11-28 2002-06-11 Irina Alekseevna Komissarova Pharmaceutical composition, the use thereof and method for producing said composition
RU2203042C2 (ru) 2000-11-28 2003-04-27 Комиссарова Ирина Алексеевна Фармацевтическая композиция и способ ее получения
FR2822834B1 (fr) * 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US6780437B2 (en) * 2001-10-23 2004-08-24 Upsher-Smith Laboratories, Inc. Coated potassium chloride granules and tablets
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
KR20050005437A (ko) * 2002-04-09 2005-01-13 플라멜 테크놀로지스 아목시실린의 변형 방출을 위한 마이크로캡슐 수성 현탁액형태의 경구 제약학적 제제
CA2480826C (fr) 2002-04-09 2012-02-07 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US7538094B2 (en) * 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
CA2520660C (en) * 2003-03-28 2013-08-20 Sigmoid Biotechnologies Limited Solid oral dosage form containing seamless microcapsules
DE10315640A1 (de) * 2003-04-04 2004-10-14 Ignatov, Konstantin Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
FR2860516B1 (fr) * 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
BRPI0506710A (pt) * 2004-01-06 2007-05-02 Panacea Biotec Ltd composições farmacêuticas de liberação controlada
EP2444071A1 (en) * 2004-09-27 2012-04-25 Sigmoid Pharma Limited Minicapsule formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
JP2008525313A (ja) * 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
CA2598668A1 (en) * 2005-02-25 2006-09-08 Mutual Pharmaceutical Company, Inc. Dosage forms of antibiotics and combinations of antibiotics and symptomatic relief agents
FR2885526B1 (fr) * 2005-05-13 2007-07-27 Flamel Technologies Sa Medicament oral a base d'inhibiteur de pompe a protons
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
EP2079456B1 (en) 2007-04-04 2012-12-05 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
EP2586428B1 (en) * 2007-04-26 2023-11-08 Sublimity Therapeutics Limited Manufacture of multiple minicapsules
CA2685591A1 (en) * 2007-05-01 2008-11-06 Sigmoid Pharma Limited Pharmaceutical nimodipine compositions
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
ES2649112T3 (es) 2009-05-18 2018-01-10 Sigmoid Pharma Limited Composición que comprende gotas de aceite
CN107582526A (zh) 2009-08-12 2018-01-16 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CA2902911C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
EP3881829A1 (en) 2014-11-07 2021-09-22 Sublimity Therapeutics Limited Compositions comprising cyclosporin
US10363288B2 (en) 2015-01-14 2019-07-30 National Jewish Health Insulin mimotopes and methods of using the same
EP3302458B1 (en) * 2015-05-28 2022-09-07 The Regents of The University of Colorado, A Body Corporate Methods of preventing and treating autoimmunity
US10272327B2 (en) * 2017-07-13 2019-04-30 Performance Designed Products Llc Detachable joystick for video game controller
USD890846S1 (en) 2017-08-07 2020-07-21 Performance Designed Products Llc Video game controller
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
USD1034816S1 (en) 2022-03-07 2024-07-09 Performance Designed Products Llc Video game controller

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2996431A (en) * 1953-12-16 1961-08-15 Barry Richard Henry Friable tablet and process for manufacturing same
US2853420A (en) * 1956-01-25 1958-09-23 Lowey Hans Ethyl cellulose coatings for shaped medicinal preparations
US3155590A (en) * 1962-08-02 1964-11-03 Ncr Co Encapsulation process and its product
US3341416A (en) * 1963-12-11 1967-09-12 Ncr Co Encapsulation of aspirin in ethylcellulose and its product
FR5788M (no) * 1965-11-18 1968-03-18
US3488418A (en) * 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition
US3557279A (en) * 1969-06-12 1971-01-19 Merck & Co Inc Microencapsulation form of an anti-inflammatory drug
US3703576A (en) * 1969-08-08 1972-11-21 Fuji Photo Film Co Ltd Method of producing micro-capsules enclosing acetylsalicylic acid therein
DE2200778B2 (de) * 1971-01-13 1974-04-18 Sandoz Ag, Basel (Schweiz) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
US3909444A (en) * 1971-08-05 1975-09-30 Ncr Co Microcapsule
JPS523342B2 (no) * 1972-01-26 1977-01-27
FR2183546B1 (no) * 1972-05-10 1975-06-20 Servier Lab
GB1403584A (en) * 1972-05-19 1975-08-28 Beecham Group Ltd Control medicaments
JPS5438164B2 (no) * 1972-05-29 1979-11-19
BE791458A (fr) * 1972-07-31 1973-05-16 Merck & Co Inc Produit microencapsule
FR2236483B1 (no) * 1973-07-12 1976-11-12 Choay Sa
US4113816A (en) * 1973-07-12 1978-09-12 Choay S.A. Process for the manufacture of layered tablets incorporating controlled-release microcapsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
JPS603286B2 (ja) * 1977-03-03 1985-01-26 日本化薬株式会社 定速溶出性製剤
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
CA1165241A (en) * 1980-05-06 1984-04-10 Bristol-Myers Squibb Company Sustained release theophylline tablet having reduced bulk
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof

Also Published As

Publication number Publication date
DK457984D0 (da) 1984-09-25
DK457984A (da) 1984-09-25
HU187215B (en) 1985-11-28
DE3490030T1 (de) 1985-02-21
SE8404804L (sv) 1984-09-25
CH661659A5 (de) 1987-08-14
US4748023A (en) 1988-05-31
BE898888A (fr) 1984-08-13
WO1984002843A1 (en) 1984-08-02
GB2143734A (en) 1985-02-20
NL8420009A (nl) 1984-12-03
FR2559389A1 (fr) 1985-08-16
FI843773L (fi) 1984-09-26
GB8423339D0 (en) 1984-10-17
FI843773A0 (fi) 1984-09-26
SU1535369A3 (ru) 1990-01-07
FI843773A7 (fi) 1984-09-26
GB2143734B (en) 1986-07-30
JPS60500213A (ja) 1985-02-21
SE458092B (sv) 1989-02-27
FR2559389B1 (fr) 1986-05-30
SE8404804D0 (sv) 1984-09-25

Similar Documents

Publication Publication Date Title
NO843563L (no) Fremgangsmaate ved fremstilling av farmasoeytiske preparater med hoeyt innhold av aktiv bestanddel som frigjoeres over lengre tid
DE3372845D1 (en) Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof
HUT51617A (en) Process for producing oxadiazole derivatives and pharmaceutical preparations containing these compounds as active substance
IL60510A (en) Derivatives of n-(mercaptoalkylcarbonyl)glycine,processes for their preparation and pharmaceutical compositions containing them
HU179793B (en) Process for preparing 4-amino-5-sulphonyl-o-anisamide derivatives and pharmaceutical preparations containing such compounds as active materials
PT71724B (en) Process for the preparation of new optically active 1,4-dihidropyridine derivatives having anti-hypertensive and vasodilator effect and of pharmaceutical compositions containing them
IL68267A (en) Derivatives of cycloalka(c),pyrrolcarboxylic acids,process for their preparation,and pharmaceutical compositions containing them
PT86236A (en) Process for the preparation of catechol derivatives and of pharmaceutical compositions containing them
HUT37424A (en) Process for preparing new 5-pyridyl-1,3-thiazoie derivatives and pharmaceutical compositions containing thereof as active substances
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
DE3366393D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
AR243515A1 (es) Un procedimiento para la obtencion de derivados de tiazol activos sobre el sistema colinergico.
HU173465B (hu) Sposob poluchenija proizvodnykh tieno-benzoksepinil-uksusnojj kisloty i farmacevticheskikh preparatov soderzhahhikh takie soedineija kak aktivnye behhestva
IL57901A0 (en) Indanyl derivatives,process for their preparation and pharmaceutical preparations containing them
NO172230C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser, samt forbindelser som er mellomprodukter ved fremgangsmaaten
NO158876C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
AU583255B2 (en) New benzenesulfonyl-lactams, process for their preparation and their use as active substances of pharmaceutical compositions
EP0002680A3 (en) 4-spectinomycylamin and its physiologically acceptable salts, method of preparation and pharmaceutical products containing these substances
AU586410B2 (en) New cyclic benzenesulfonamides, process for their preparation and their use as active substance of pharmaceutical compositions
CS189028B2 (en) Fundicide and bactericide preparations for the suppression of maladies and method of preparation the active substances
HUT37036A (en) Process for preparing pharmaceutical compositions with retarded release of the active substance
DK164865C (da) Silibininderivater, fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende silibininderivaterne
FI891712A7 (fi) Terapeuttisesti vaikuttavia syklometyleeni-1,2-bikarboksyylihappojen amiineja, menetelmiä niiden valmistamiseksi sekä niitä sisältäviä farmaseuttisia koostumuksia
PT76951B (en) Process for the preparation of racemic or optically active eburnane-oxime derivatives and pharmaceutical compositions containing them